Extended Curettage for Local Control of Chondromyxoid Fibroma: A 33‐Year Experience at a Single Tertiary Center
BACKGROUND AND OBJECTIVES: The management of chondromyxoid fibroma (CMF) primarily relies on surgical resection, but simple curettage is reportedly associated with a high local recurrence rate. While extended curettage with high-speed burring effectively manages other locally aggressive bone tumors, its effectiveness for CMF remains unclear. We aimed to evaluate the outcome of this technique for CMF. METHODS: We retrospectively reviewed 31 CMF patients treated at a single tertiary academic hospital between 1990 and 2023. Demographics and treatment details were collected. The primary outcome was local recurrence-free survival for the patients who underwent extended curettage and had follow-up for more than 6 months. The secondary outcome was complications. RESULTS: The median age was 41 (IQR, 18-47), and 61% were male. Of the total 31 patients, 26 underwent extended curettage with high-speed burring, while five underwent en bloc resection. No local recurrence occurred in either group. Among the extended curettage group, 21 had a follow-up of more than 6 months (median follow-up: 37 months [IQR, 18-58 months]), only one complication (symptomatic hardware removal) was recorded. CONCLUSIONS: Extended curettage with high-speed burring was associated with excellent local control and few complications, making it a desirable surgical option for CMF.
Authors
- Liuzhe Zhang (ORCID: https://orcid.org/0000-0003-0656-2365)
- Peter C. Ferguson (ORCID: https://orcid.org/0000-0003-2630-112X)
- Aaron Gazendam (ORCID: https://orcid.org/0000-0002-2615-4919)
- Anthony M. Griffin (ORCID: https://orcid.org/0000-0003-4462-3974)
- Kim Tsoi
- Jay S. Wunder
- David Clever
Institutions
- Mount Sinai Hospital (CA)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2026-09-14
- DOI
- https://doi.org/10.1002/jso.70385
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00